Captor Therapeutics ®
News
May 29, 2023
Captor Therapeutics publishes Q1 2023 financial results
April 07, 2023
Captor Therapeutics has published its 2022 report. The past year was a period of dynamic growth for the Company in both science and business.
March 27, 2023
Captor Therapeutics Discloses Molecular Targets of Pipeline’s Lead Assets and Invites Stakeholders to Webcast
March 06, 2023
Captor Therapeutics Announces Three-Year Strategic Objectives
December 19, 2022
Captor Therapeutics senior management to hold investor and partnering meetings around J.P. Morgan 41st Annual Healthcare Conference
November 24, 2022
Captor Therapeutics reports Q3 2022 results and provides business update. Lead assets approaching the clinic and new significant drug discovery collaboration signed with Ono Pharmaceutical
November 14, 2022
Ono Pharmaceutical and Captor Therapeutics announce drug discovery collaboration to develop small molecule protein degraders for the treatment of neurodegenerative diseases
September 20, 2022
Captor Therapeutics announces participation in upcoming scientific, investor, and partnering conferences in October 2022